Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corticosteroids for Acute Respiratory Distress Syndrome
NCT07711964Phase 4Recruiting
- Sponsor
- National Taiwan University Hospital
- Start
- Jun 2025
- Primary completion
- Apr 2030
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexamethasone in acute respiratory distress syndrome (ARDS) (6 arms), sponsored by National Taiwan University Hospital. Primary endpoint: 28-day ventilator-free survival. Started Jun 2025; status: recruiting.
02
Drugs
dexamethasone
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT07711964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07711964.